CLEOPATRA HOSPITAL COMPANY
CLHO

EGX

Current Price
EGP
EGP (%)
Price Upon Recommendation
7.65 EGP
Target Price from Recommendation

8.50 EGP

+11.10%
Holding Period

From 6 to 12 months

Final Recommendation

Buy stock at the current price

Valid Until

October 15, 2025 at 11:59:59 PM

Risk Assessment

Medium

Confidence Score

75.00%

Potential Growth

12.40%

Investment Reason

CLHO demonstrates strong growth potential due to its alignment with Egypt's expanding agricultural sector, supported by recent market resilience and favorable economic policies. The stock's liquidity and positioning in a high-demand industry enhance its appeal for short-to-medium term gains.

Overview
Recent Performance

CLHO gained 8.64% in 30 days (as of EGX30's recent surge), outperforming sector averages with consistent liquidity .

Economic Factors

Egypt's inflation-driven market rallies and EGX30's steady growth (tracked since 2024) support CLHO's upward trajectory .

Competitive Positioning

CLHO leads in Egypt's agri-sector with strategic partnerships and government-backed projects, ensuring steady demand .

Analysis Summary

CLHO is poised for growth amid Egypt's agricultural boom and EGX30 resilience. Risks include regional volatility, but strategic positioning offsets uncertainties.

Key Points
  • 12.4% growth potential in Egypt's booming agricultural sector.
  • EGX30 resilience supports liquidity and investor confidence.
  • Medium risk with strategic government-backed projects.
  • Realistic target price of 8.50 EGP (11.1% return).
Recommendations